A peer-reviewed, evidence-based journal that promotes clinical development and metabolic insights in total bariatric patient care for the healthcare professional
Issue link: http://bariatrictimes.epubxp.com/i/800348
21 The Medical Student Notebook Bariatric Times • March 2017 42. Acheson JF, WT Green, Sanders MD. Optic nerve sheath decompression for the treatment of visual failure in chronic raised intracranial pressure. J Neurol Neurosurg Psychiatry. 1994;57:1426–1429. 43. Corbett JJ, Nerad JA, Tse DT, et al. Results of optic nerve sheath fenestration for pseudotumor cerebri. Arch Ophthalmol. 1988; 106:1391–1397. 44. Brourman ND, Spoor TC, Ramocki JM. Optic nerve sheath decompression for pseudotumor cerebri. Arch Ophalmol. 1988;106: 1378–1383. 45. Johnston I, Kollar C, Dunkley S, et al. Cranial venous outflow obstruction in the pseudotumour syndrome: incidence, nature and relevance. J Clin Neurosci. 2002; 9:273. 46. Lee AG, Brazis PW. Magnetic resonance venography in idiopathic pseudotumor cerebri. J Neuroophthalmol. 2000; 20:12. 47. Higgins JN, Tipper G, Varley M, Pickard JD. Transverse sinus stenoses in benign intracranial hypertension demonstrated on CT venography. Br J Neurosurg. 2005; 19:137. 48. Farb RI, Vanek I, Scott JN, et al. Idiopathic intracranial hypertension: the prevalence and morphology of sinovenous stenosis. Neurology. 2003; 60:1418. 49. Glueck CJ, Iyengar S, Goldenberg N, et al. Idiopathic intracranial hypertension: associations with coagulation disorders and polycystic-ovary syndrome. J Lab Clin Med. 2003; 142:35. 50. Ooi LY, Walker BR, Bodkin PA, Whittle IR. Idiopathic intracranial hypertension: can studies of obesity provide the key to understanding pathogenesis? Br J Neurosurg. 2008; 22:187. 51. Skau M, Brennum J, Gjerris F, Jensen R. What is new about idiopathic intracranial hypertension? An updated review of mechanism and treatment. Cephalalgia. 2006; 26:384. 52. Sugerman HJ, DeMaria EJ, Felton WL 3rd, et al. Increased intra- abdominal pressure and cardiac filling pressures in obesity- associated pseudotumor cerebri. Neurology. 1997; 49:507. 53. Sugerman HJ, Felton III WL 3rd, Sismanis A, et al. Continuous negative abdominal pressure device to treat pseudotumor cerebri. Int J Obes Relat Metab Disord. 2001; 25:486. 54. Friedman DI. Cerebral venous pressure, intra-abdominal pressure, and dural venous sinus stenting in idiopathic intracranial hypertension. J Neuroophthalmol. 2006; 26:61. 55. Digre KB, Varner MW, Corbett JJ. Pseudotumor cerebri and pregnancy. Neurology. 1984; 34:721. 56. Lee AG, Golnik K, Kardon R, et al. Sleep apnea and intracranial hypertension in men. Ophthalmology. 2002; 109:482. 57. Bruce BB, Kedar S, Van Stavern GP, et al. Idiopathic intracranial hypertension in men. Neurology. 2009; 72:304. 58. Burgett RA, Purvin VA, Kawasaki A. Lumboperitoneal shunting for pseudotumor cerebri. Neurology. 1997; 49:734. 59. McCarthy KD, Reed DJ. The effect of acetazolamide and furosemide on cerebrospinal fluid production and choroid plexus carbonic anhydrase activity. J Pharmacol Exp Ther. 1974; 189:194. 60. NORDIC Idiopathic Intracranial Hypertension Study Group Writing Committee, Wall M, McDermott MP, et al. Effect of acetazolamide on visual function in patients with idiopathic intracranial hypertension and mild visual loss: the idiopathic intracranial hypertension treatment trial. JAMA. 2014; 311:1641. 61. Horton JC. Acetazolamide for pseudotumor cerebri: Evidence from the NORDIC Trial. JAMA. 2014;311:1618–1619. 62. Gücer G, Viernstein L. Long-term intracranial pressure recording in the management of pseudotumor cerebri. J Neurosurg. 1978; 49:256. 63. Biousse V, Bruce BB, Newman NJ. Update on the pathophysiology and management of idiopathic intracranial hypertension. J Neurol. 2012;83(5):488–494. 64. Matthews YY. Drugs used in childhood idiopathic or benign intracranial hypertension. Arch Dis Child Educ Pract Ed. 2008; 93:19. 65. Schoeman JF. Childhood pseudotumor cerebri: clinical and intracranial pressure response to acetazolamide and furosemide treatment in a case series. J Child Neurol. 1994; 9:130. 66. Förderreuther S, Straube A. Indomethacin reduces CSF pressure in intracranial hypertension. Neurology. 2000; 55:1043.